MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) announced Friday that CEO Adam Bierman is stepping down from the role effective Feb. 1.
Ryan Lissack, the cannabis company's chief operating officer and chief technology officer, has been named interim CEO.
Bierman To Surrender Class A Shares
Bierman is also agreeing to return his Class A super voting shares to MedMen, the company said.
The surrendering of the Super Voting Shares leaves the company with subordinate voting shares as its only remaining outstanding shares.
The CEO's resignation comes after a restructuring effort that included 190 layoffs.
In an interview published earlier this month, Bierman told Benzinga: "We're on chapter two, where execution means …
Full story available on Benzinga.com